BENZENO SHARON (CIK 1780854) reported 26 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-06-30). Recent activity: Buy ADPT (11,034 shares), Sell ADPT (11,034 shares), Buy ADPT (1,837 shares), Buy ADPT (24,944 shares), Buy ADPT (24,944 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-30 | Adaptive Biotechnologies Corp (ADPT) | Chief Commercial Ofc Imm Med | Buy | 11,034 | $133,953 |
| 2026-06-30 | Adaptive Biotechnologies Corp (ADPT) | Chief Commercial Ofc Imm Med | Sell | 11,034 | $231,714 |
| 2026-06-30 | Adaptive Biotechnologies Corp (ADPT) | Chief Commercial Ofc Imm Med | Buy | 1,837 | $22,301 |
| 2026-06-30 | Adaptive Biotechnologies Corp (ADPT) | Chief Commercial Ofc Imm Med | Buy | 24,944 | $211,026 |
| 2026-06-30 | Adaptive Biotechnologies Corp (ADPT) | Chief Commercial Ofc Imm Med | Buy | 24,944 | $99,527 |
| 2026-06-30 | Adaptive Biotechnologies Corp (ADPT) | Chief Commercial Ofc Imm Med | Buy | 51,570 | $418,748 |
| 2026-06-30 | Adaptive Biotechnologies Corp (ADPT) | Chief Commercial Ofc Imm Med | Sell | 154,768 | $3.3M |
| 2026-03-13 | Adaptive Biotechnologies Corp (ADPT) | Chief Commercial Ofc Imm Med | Sell | 63,103 | $831,067 |
| 2026-03-06 | Adaptive Biotechnologies Corp (ADPT) | Chief Commercial Ofc Imm Med | Buy | 39,063 | $0 |
| 2025-12-08 | Adaptive Biotechnologies Corp (ADPT) | Chief Commercial Ofc Imm Med | Buy | 4,290 | $52,081 |
| 2025-12-08 | Adaptive Biotechnologies Corp (ADPT) | Chief Commercial Ofc Imm Med | Buy | 4,157 | $35,168 |
| 2025-12-08 | Adaptive Biotechnologies Corp (ADPT) | Chief Commercial Ofc Imm Med | Buy | 4,157 | $16,586 |
| 2025-12-08 | Adaptive Biotechnologies Corp (ADPT) | Chief Commercial Ofc Imm Med | Sell | 12,604 | $212,377 |
| 2025-11-24 | Adaptive Biotechnologies Corp (ADPT) | Chief Commercial Ofc Imm Med | Buy | 834 | $5,229 |
| 2025-11-24 | Adaptive Biotechnologies Corp (ADPT) | Chief Commercial Ofc Imm Med | Buy | 68,961 | $837,187 |
| 2025-11-24 | Adaptive Biotechnologies Corp (ADPT) | Chief Commercial Ofc Imm Med | Sell | 297,925 | $4.9M |
| 2025-11-24 | Adaptive Biotechnologies Corp (ADPT) | Chief Commercial Ofc Imm Med | Buy | 133,032 | $1.1M |
| 2025-11-24 | Adaptive Biotechnologies Corp (ADPT) | Chief Commercial Ofc Imm Med | Buy | 20,834 | $136,463 |
| 2025-11-24 | Adaptive Biotechnologies Corp (ADPT) | Chief Commercial Ofc Imm Med | Buy | 49,480 | $324,094 |
| 2025-11-24 | Adaptive Biotechnologies Corp (ADPT) | Chief Commercial Ofc Imm Med | Buy | 34,375 | $249,906 |
| 2025-11-24 | Adaptive Biotechnologies Corp (ADPT) | Chief Commercial Ofc Imm Med | Buy | 119,809 | $1.5M |
| 2025-11-24 | Adaptive Biotechnologies Corp (ADPT) | Chief Commercial Ofc Imm Med | Buy | 83,145 | $331,749 |
| 2025-11-24 | Adaptive Biotechnologies Corp (ADPT) | Chief Commercial Ofc Imm Med | Sell | 308,477 | $5.2M |
| 2025-03-06 | Adaptive Biotechnologies Corp (ADPT) | Chief Commercial Ofc Imm Med | Buy | 109,973 | $0 |
| 2025-03-06 | Adaptive Biotechnologies Corp (ADPT) | Chief Commercial Ofc Imm Med | Sell | 41,600 | $290,368 |
Source: SEC Form 4 filings · as of 2026-06-30